ONSIGHT MEDICAL WINS TCT CONNECT 2020 SHARK TANK INNOVATION COMPETITION
Science Magazine, October 16, 2020
The Cardiovascular Research Foundation (CRF) is pleased to announce that OnSight Medical, an AI-based company specializing in cardiac ultrasound imaging, has won the TCT 2020 Shark Tank Innovation Competition which took place during the Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier educational meeting specializing in interventional cardiovascular medicine. The winner was also presented with the Jon DeHaan Foundation Award for Interventional Innovation.
ARIA CV NETS $31M TO SUPPORT FIRST US CLINICAL STUDY OF ITS IMPLANT
MedCity News, Joel Berg, February 26, 2020
The implant — designated a breakthrough device by the FDA — would treat patients with pulmonary arterial hypertension. The progressive disease leads to heart failure but is usually treated with medication.
JON DEHAAN FOUNDATION ANNOUNCES NEW PRESIDENT
Accesswire, March 17, 2020
The Jon DeHaan Foundation is proud to announce Dr. Robert Schwartz of the Minneapolis Heart Institute as its new President. Dr. Schwartz will lead the organization in supporting individuals and companies bringing groundbreaking research in cardiac medicine towards commercialization.
YOKNE’AM’S HEALIUM MEDICAL WINS ICI AWARD
By JERUSALEM POST STAFF
DECEMBER 15, 2019 11:08
Sixty-three companies from all over the world competed for the Innovation in Cardiovascular Interventions Conference award.
TCT 2019: SYSTEM FOR MANAGING DEEP VEIN REFLUX WINS SHARK TANK AWARD
VascularNews.com, October 7, 2019
At the 2019 Transcatheter Cardiovascular Therapeutics (TCT) meeting (25–29 September, San Francisco, USA), InterVene won the TCT-Shark Tank Innovation Competition for its novel endovenous system (BlueLeaf) for forming valves in patients with deep vein reflux and/or chronic venous insufficiency. The award, which is supported by the Jon DeHaan Foundation, means that the company receives $200,000 to further develop their device.
ISRAELI MEDICAL DEVICE STARTUP FILTERLEX RAISES $3M FOR ITS EMBOLIC PROTECTION DEVICE
NoCamels.com, Miranda DiPaolo, July 22, 2019
Filterlex Medical, an Israeli startup developing a next-generation embolic protection device, announced last week they have completed a Series funding round raising a total of $3 million in capital.
The Yokneam-based company has developed the Captis embolic protection device that reduces the risk of stroke and other complications during catheter-based structural heart procedures.
JONATHON LEIPSIC AWARDED 2019 DEHAAN AWARD FOR INNOVATION IN CARDIOLOGY
Dicardiology.com, July 8, 2019
Leipsic to use $200,000 grant from annual SCCT award to further research on mechanisms of bioprosthetic valve failure
ARIA CV AWARDED TOP PRIZE AT TCT’S 2018 SHARK TANK COMPETITION
CathLabDigest.com, October 9, 2018
Cardiovascular Research Foundation presents Aria with the Jon DeHaan Foundation Award for Interventional Innovation
HAN AWARDED THE INAUGURAL 2018 DEHAAN AWARD FOR INNOVATION IN CARDIOLOGY
SCCT.org, Claire Johns, August 13, 2018
B. Kelly Han, MD, FSCCT, is the recipient of the inaugural 2018 DeHaan Award for Innovation in Cardiology, and presented the first DeHaan Award Lecture at the Society of Cardiovascular Computed Tomography (SCCT) 13th Annual Scientific Meeting in Dallas, Texas on July 13. The award, presented by the Jon DeHaan Foundation includes a $200,000 grant.